Day Zero Diagnostics Announces Completion of $16M Financing Round
BOSTON, Sept. 20, 2023 -- (Healthcare Sales & Marketing Network) -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, an... Diagnostics, Venture Capital Day Zero Diagnostics, epiXact, antibiotic resistance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2023 Category: Pharmaceuticals Source Type: news
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
CAESAREA, Israel, Sept. 20, 2023 -- (Healthcare Sales & Marketing Network) -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to su... Devices, FDA IceCure Medical, ProSense System, cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2023 Category: Pharmaceuticals Source Type: news
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain
MARLBOROUGH, Mass., Sept. 19, 2023 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE:... Devices, Mergers & Acquisitions Boston Scientific, Relievant Medsystems, Intracept System, vertebrogenic pain (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2023 Category: Pharmaceuticals Source Type: news
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
ATLANTA, Sept. 18, 2023 -- (Healthcare Sales & Marketing Network) -- MiRus announces limited market release in the U.S. of its ATLAS™ MoRe® Foot and Ankle Plating System, the thinnest foot and ankle plate on the market for treatment of foot and ankle... Devices, Orthopaedic, Product Launch MiRus, Atlas, Foot and Ankle Plating System, molybdenum, rhenium (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2023 Category: Pharmaceuticals Source Type: news
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Funding supports development and testing of proprietary FieldBending™ catheter ablation platform
CARDIFF-BY-THE-SEA, Calif., Sept. 18, 2023 -- (Healthcare Sales & Marketing Network) -- Field Medical, Inc. (Field Medical), an emerging leader in cardiac ... Devices, Interventional, Cardiology, Venture Capital Field Medical, field ablation system, pulse field ablation, catheter ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2023 Category: Pharmaceuticals Source Type: news
SmartCardia Receives FDA Clearance for its 14-Day 7-Lead ECG Real-Time Patch and Cloud Platform
LAUSANNE, Switzerland, Sept. 15, 2023 -- (Healthcare Sales & Marketing Network) -- SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform. SmartCardia's 7L patch is easy-to-wear, cable-free, waterproof and ... Devices, Cardiology, Monitoring, FDA SmartCardia, 7L patch, real-time ECG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 15, 2023 Category: Pharmaceuticals Source Type: news
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
ALASTIN adds to their solution serums with a radically new form of Vitamin C for skin that looks smoother & more radiant
DALLAS, Sept. 14, 2023 -- (Healthcare Sales & Marketing Network) -- Galderma, the emerging pure-play dermatology category leader, a... Biopharmaceuticals, Dermatology, Product Launch Galderma, C-RADICAL, Defense Antioxidant Serum (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2023 Category: Pharmaceuticals Source Type: news
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
GENEVA, Sept. 14, 2023 -- (Healthcare Sales & Marketing Network) -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients.... Devices, Interventional, Cardiology MedAlliance, SELUTION SLR, drug-eluting balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2023 Category: Pharmaceuticals Source Type: news
Dignify Therapeutics and Aayam Therapeutics enter into licensing agreement for novel on-demand defecation drug
Agreement expands Dignify's intellectual property portfolio
RESEARCH TRIANGLE PARK, N.C. and SAN JOSE, Calif., Sept. 13, 2023 -- (Healthcare Sales & Marketing Network) -- Dignify Therapeutics (Dignify), a pharmaceutical and medical device development c... Biopharmaceuticals, Licensing Dignify Therapeutics, Aayam Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2023 Category: Pharmaceuticals Source Type: news
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Appointment effective as of September 14, 2023; Zeev Bronfeld to retire from the Board of Directors
CARMIEL, Israel, Sept. 12, 2023 (Healthcare Sales & Marketing Network) Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company ... Biopharmaceuticals, Personnel Protalix BioTherapeutics, ProCellEx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2023 Category: Pharmaceuticals Source Type: news
OnPoint Surgical Receives 510(k) Clearance for the OnPoint Augmented Reality Spine System
BOSTON, Sept. 11, 2023 -- (Healthcare Sales & Marketing Network) -- OnPoint Surgical, Inc., a member of a group of privately held OnPoint companies pioneering augmented reality (AR) technology and artificial intelligence (AI) for multiple verticals includ... Devices, Orthopaedic, Neurosurgery, FDA OnPoint Surgical, Augmented Reality Spine System, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2023 Category: Pharmaceuticals Source Type: news
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Resubmission to FDA planned for early 2024
CRANFORD, N.J., Sept. 8, 2023 -- (Healthcare Sales & Marketing Network) -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) is pleased to announce the Company has rec... Biopharmaceuticals, Oncology, FDA Citius Pharmaceuticals, LYMPHIR, denileukin diftitox, T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2023 Category: Pharmaceuticals Source Type: news
IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress
ProSense is gaining commercial traction in Europe where it has CE approval for numerous malignant and benign tissue indications.
Symposium presenters include Professor Francois Cornelis who used ProSense in an endometriosis study which demonstrated cryo... Devices IceCure Medical, ProSense System, cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2023 Category: Pharmaceuticals Source Type: news
Sharps Terminator Launches Innovative Device to Reduce Sharps Medical Plastic Waste by 93%
FDA-approved medical device enhances safety and sustainability in healthcare
Lubbock, TX, Sept. 7, 2023 -- (Healthcare Sales & Marketing Network) -- Sharps Terminator, LLC is proud to announce the USA launch of its revolutionary medical device designed ... Devices, Product Launch Sharps Terminator, needlestick (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2023 Category: Pharmaceuticals Source Type: news
Silony Medical acquires Centinel Spine's Global Fusion Business
The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform
FRAUENFELD, Switzerland, Sept. 7, 2023 -- (Healthcare Sales & Marketing Network) -- Silony Medical International AG (the company), a growing... Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions Silony Medical, Centinel Spine, Interbody Fusion, spinal fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2023 Category: Pharmaceuticals Source Type: news
